Shiraki M, Ito H, Fujimaki H, Higuchi T
Department of Laboratory Medicine, Tokyo Metropolitan Geriatric Hospital, Japan.
Endocrinol Jpn. 1991 Aug;38(4):343-9. doi: 10.1507/endocrj1954.38.343.
We studied the relation between body size and bone mineral density in elderly females. The study included a total of 93 ambulatory females aged over 60 years. They were divided into 3 groups according to their body mass index (BMI; kg/m2): slender group with BMI less than 20 (n = 28), normal group with BMI of 20 to 24.9 (n = 43) and obese group with BMI greater than or equal to 25 (n = 22). Fracture incidence, bone mineral density, calcium regulating hormones and steroid hormones were studied in an intergroup comparative manner. The incidence of vertebral fracture was found to be negatively correlated with BMI (the incidences of vertebral fracture in slender, normal and obese were 78.6, 48.8 and 22.7%, respectively) and bone mineral density was also BMI-related (0.390 +/- 0.016, 0.456 +/- 0.015 and 0.493 +/- 0.018 g/cm2, respectively: p less than 0.01 in ANOVA; mean +/- SE). The number of years after menopause was shorter in patients with a higher BMI. There was no intergroup difference in serum levels of PTH, vitamin D and estrogens. On the other hand, serum levels of calcitonin, DHEA, DHEAS, delta-4 androstenedione and testosterone were found to be higher in subjects with a higher BMI. From the present results, it seems that bone mineral density is supported not only by weight-bearing stress upon bone, but also by serum levels of calcitonin and androgens in obese females.
我们研究了老年女性身体尺寸与骨矿物质密度之间的关系。该研究共纳入了93名60岁以上的非卧床女性。根据她们的体重指数(BMI;kg/m²)将她们分为3组:BMI小于20的消瘦组(n = 28)、BMI为20至24.9的正常组(n = 43)以及BMI大于或等于25的肥胖组(n = 22)。以组间比较的方式研究了骨折发生率、骨矿物质密度、钙调节激素和甾体激素。发现椎体骨折的发生率与BMI呈负相关(消瘦组、正常组和肥胖组的椎体骨折发生率分别为78.6%、48.8%和22.7%),骨矿物质密度也与BMI相关(分别为0.390±0.016、0.456±0.015和0.493±0.018 g/cm²:方差分析中p<0.01;均值±标准误)。BMI较高的患者绝经后的年限较短。甲状旁腺激素、维生素D和雌激素的血清水平在组间无差异。另一方面,发现BMI较高的受试者降钙素、脱氢表雄酮、硫酸脱氢表雄酮、δ-4雄烯二酮和睾酮的血清水平较高。从目前的结果来看,似乎肥胖女性的骨矿物质密度不仅受到骨骼上负重压力的支持,还受到降钙素和雄激素血清水平的支持。